New Launch2 Jan 2025, 08:47 pm
Divi's Laboratories Commences Commercial Operations at Phase I of Unit III Greenfield Project
AI Summary
Divi's Laboratories, a renowned pharmaceutical company, has initiated commercial operations from a part of the Phase I of Unit III greenfield project at Ontimamidi Village, Thondangi Mandal, Kakinada, Andhra Pradesh from January 01, 2025. The Phase I of the Unit III greenfield project, spread over 200 acres of the 500 acres Unit III site, was estimated to require an investment between INR 31,200 crores to INR 32,700 crores. However, due to a delay in receiving confirmation of the commencement of commercial operations after completing required paperwork on January 01, 2025, the company was able to file this intimation on January 02, 2025.
Key Highlights
- Divi's Laboratories commences commercial operations at Phase I of Unit III greenfield project.
- The project is spread over 200 acres of the 500 acres Unit III site in Kakinada, Andhra Pradesh.
- The estimated investment for the Phase I of the project is between INR 31,200 crores to INR 32,700 crores.
- The commercial operations commenced from January 01, 2025.
- The intimation was filed on January 02, 2025 due to delay in confirmation of commencement of commercial operations.